Researcher seeks answers for epigenetic abnormalities leading to cancer diagnoses
Chemical Biology and Medicinal Chemistry Brittany Jennings October 30, 2019 Lindsey Ingerman James, Ph.D. Lindsey Ingerman James, Ph.D., with the UNC Eshelman School of Pharmacy is interested in epigenetic abnormalities that lead to cancer. For example, misregulation of the NSD2 … Read more